These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 11140914)

  • 1. Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry.
    Wang SA; Panlilio AL; Doi PA; White AD; Stek M; Saah A
    Infect Control Hosp Epidemiol; 2000 Dec; 21(12):780-5. PubMed ID: 11140914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of HIV Postexposure Prophylaxis in healthcare workers after occupational exposure: a Thai university hospital setting.
    Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
    J Med Assoc Thai; 2006 Jul; 89(7):974-8. PubMed ID: 16881429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-exposure prophylaxis of HIV infection in out-patient clinic of hospital for infectious diseases in Warsaw in 2001-2002].
    Kowalska JD; Firlag-Burkacka E; Niezabitowska M; Bakowska E; Ignatowska A; Pulik P; Horban A
    Przegl Epidemiol; 2006; 60(4):789-94. PubMed ID: 17682761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant intolerability of efavirenz in HIV occupational postexposure prophylaxis.
    Wiboonchutikul S; Thientong V; Suttha P; Kowadisaiburana B; Manosuthi W
    J Hosp Infect; 2016 Apr; 92(4):372-7. PubMed ID: 26876748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Danish PEP Registry: Experience with the use of post-exposure prophylaxis following blood exposure to HIV from 1999-2012.
    Lunding S; Katzenstein TL; Kronborg G; Storgaard M; Pedersen C; Mørn B; Lindberg JÅ; Kronborg TM; Jensen J
    Infect Dis (Lond); 2016; 48(3):195-200. PubMed ID: 26529586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus postexposure prophylaxis for occupational exposure in a medical school hospital in Thailand.
    Hiransuthikul N; Hiransuthikul P; Kanasuk Y
    J Hosp Infect; 2007 Dec; 67(4):344-9. PubMed ID: 18023920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana.
    Tetteh RA; Nartey ET; Lartey M; Mantel-Teeuwisse AK; Leufkens HG; Nortey PA; Dodoo AN
    BMC Public Health; 2015 Jun; 15():573. PubMed ID: 26092496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service
    MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of HIV exposure and postexposure prophylaxis among health care workers in Greece.
    Konte V; Nikolopoulos G; Raftopoulos V; Pylli M; Tsiara C; Makri E; Paraskeva D
    Public Health Nurs; 2007; 24(4):337-42. PubMed ID: 17553023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus in traveling health care workers.
    Uslan DZ; Virk A
    J Travel Med; 2005; 12(1):14-8. PubMed ID: 15996462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of rabies pre- and postexposure prophylaxis in 290 health-care-workers exposed to a rabies infected organ donor or transplant recipients.
    Mattner F; Bitz F; Goedecke M; Viertel A; Kuhn S; Gastmeier P; Mattner L; Biertz F; Heim A; Henke-Gendo C; Engelmann I; Martens A; Strüber M; Schulz TF
    Infection; 2007 Jun; 35(4):219-24. PubMed ID: 17646909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus.
    Luque A; Hulse S; Wang D; Shahzad U; Tanzman E; Antenozzi S; Smith B
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):695-701. PubMed ID: 17520543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.
    Young TN; Arens FJ; Kennedy GE; Laurie JW; Rutherford Gw
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002835. PubMed ID: 17253483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post exposure prophylaxis following occupational exposure to HIV: a survey of health care workers in Mbeya, Tanzania, 2009-2010.
    Mponela MJ; Oleribe OO; Abade A; Kwesigabo G
    Pan Afr Med J; 2015; 21():32. PubMed ID: 26405468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the magnitude of occupational exposure to human immunodeficiency virus (HIV) and uptake of HIV post-exposure prophylaxis among healthcare workers in a rural district in Tanzania.
    Mabwe P; Kessy AT; Semali I
    J Hosp Infect; 2017 Jul; 96(3):276-280. PubMed ID: 28274607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV.
    Lee LM; Henderson DK
    Drug Saf; 2001; 24(8):587-97. PubMed ID: 11480491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine toxicity in uninfected healthcare workers. Italian Registry of Antiretroviral Prophylaxis.
    Ippolito G; Puro V
    Am J Med; 1997 May; 102(5B):58-62. PubMed ID: 9845498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Registry finds 3 drugs most favored PEP regimen.
    AIDS Alert; 1998 Jul; 13(7):75-6. PubMed ID: 11365586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.